Nanocapsulated quercetin downregulates rat hepatic MMP-13 and controls diethylnitrosamine-induced carcinoma

Papers of special note have been highlighted as: • of interest; •• of considerable

References

• 1  Sawada Y, Yoshikawa T, Nobuoka D et al. Phase 1 trial of glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunological evidence and potential for improving overall survival. Clin. Cancer Res.18,3686–3696 (2012).
  Medline CASGoogle Scholar
• 2  Ward JM, Shibata MA, Devor DE. Emerging issues in mouse liver carcinogenesis. Toxicol. Pathol.24,129–137 (1996).
  Medline CASGoogle Scholar
• 3  Jeng KS, Sheen IS, Jeng WJ. Azidothymidine treatment of hepatocellular carcinoma in rats: an in vivo study of telomerase inhibition. Hepatogastroenterology58,2091–2096 (2011).• •Depicts whether environmental carcinogen induces liver cancer in an animal model.
  Medline CASGoogle Scholar
• 4  Cuesta S, Kireev R, Garcia C et al. Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model. Mech. Ageing Dev.132,573–582 (2011).
  Medline CASGoogle Scholar
• 5  Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radic. Biol. Med.52,2013–2037 (2012).
  Medline CASGoogle Scholar
• 6  Mandal AK, Das S, Mitra M, Chakrabarti RN, Chatterjee M, Das N. Vesicular flavonoid in combating diethylnitrosamine induced hepatocarcinoma in rat model. J. Exp. Ther. Oncol.7,123–133 (2008).
  Medline CASGoogle Scholar
• 7  Aitio A, Aitio ML, Camus AM, Cardis E, Bartsch H. Cytochrome P-450 isozyme pattern is related to individual susceptibility to diethylnitrosamine-induced liver cancer in rats. Jpn J. Cancer Res.82,146–156 (1991).
  Medline CASGoogle Scholar
• 8  Ezquer M, Ezquer F, Ricca M, Allers C, Conget P. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. J. Hepatol.55,1112–1120 (2011).
  MedlineGoogle Scholar
• 9  Monk JM, Kim W, Callaway E et al. Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol.302,G153–G167 (2012).
  Medline CASGoogle Scholar
• 10  Anson M, Crain-Demoyelle AM, Baud V et al. Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J. Clin. Invest.122,586–599 (2012).
  Medline CASGoogle Scholar
• 11  Leonardi GC, Candido S, Cervello M et al. The tumor microenvironment in hepatocellular carcinoma (review). Int. J. Oncol.40,1733–1747 (2012).
  Medline CASGoogle Scholar
• 12  Mazzantini RP, de Conti A, Moreno FS. Persistent and remodelling hepatic preneoplastic lesions present differences in cell proliferation and apoptosis, as well as in p53, Bcl-2 and NF-kappa B pathways. J. Cell Biochem.103,538–546 (2008).
  Medline CASGoogle Scholar
• 13  Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J.7,1434–1441 (1993).
  Medline CASGoogle Scholar
• 14  Bergers G, Javaherian K, Lo K, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science284,808–812 (1999).
  Medline CASGoogle Scholar
• 15  Coussens ML, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science295,2387–2392 (2002).•• ••Demonstrates the relevancy of our work to investigate whether matrix metalloproteinase is required for rapidly proliferating and invading tumors.
  Medline CASGoogle Scholar
• 16  Johansson N, Ahonen M, Kahari VM. Matrix metalloproteinases in tumor invasion. Cell. Mol. Life Sci.57,5–15 (2000).
  Medline CASGoogle Scholar
• 17  Mandal AK, Das N. Sugar coated liposomal flavonoid: a unique formulation in combating carbontetrachloride induced hepatic oxidative damage. J. Drug Target.13,305–315 (2005).
  Medline CASGoogle Scholar
• 18  Ghosh A, Ghosh D, Sarkar S, Mandal AK, Thakur Choudhury S, Das N. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats. Eur. J. Cancer Prev.21,32–41 (2012).
  Medline CASGoogle Scholar
• 19  Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. Quercetin, a potent inhibitor against beta-catenin/Tcf signalling in SW480 colon cancer cells. Biochem. Biophys. Res. Commun.328,227–234 (2005).
  Medline CASGoogle Scholar
• 20  Byrne J, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev.60,1615–1626 (2008).
  Medline CASGoogle Scholar
• 21  Parveen S, Sahoo S. Polymeric nanoparticles for cancer therapy. J. Drug Target.16,108–123 (2008).
  Medline CASGoogle Scholar
• 22  Brannon-Peppas L, Blanchette J. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev.56,1649–1659 (2004).
  Medline CASGoogle Scholar
• 23  Ghosh D, Ghosh S, Sarkar S et al. Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model. Chem. Biol. Interact.186,61–71 (2010).• •Related to oxidative stress and explains that the nanocapsule-entrapped compound interacts with target cells with a much faster rate than that of free components.
  Medline CASGoogle Scholar
• 24  Kim SW, Park KC, Kim, HJ et al. Effects of collagen IV and laminin on the reconstruction of human oral mucosa. J. Biomed. Mater Res.58,108–112 (2001).
  Medline CASGoogle Scholar
• 25  Chowdhury AR, Mandal S, Goswami A et al. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy. Mol. Med.9,26–36 (2003).
  Medline CASGoogle Scholar
• 26  Hariharan S, Bhardwaj V, Bala L, Sitterberg J, Bakowasky U, Kumar MNVR. Design of estradiol loaded PLGA nano particulate formulations: a potential oral delivery system for hormone therapy. Pharm. Res.23,184–195 (2006).
  Medline CASGoogle Scholar
• 27  Opresko L, Wiley HS, Wallace RA. Proteins iodinated by the chloramines-T method appear to be degraded at an abnormally rapid rate after endocytosis. Proc. Natl Acad. Sci. USA77,1556–1560 (1980).
  Medline CASGoogle Scholar
• 28  Changtam C, de Koning HP, Ibrahim H et al. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur. J. Med. Chem.45,941–956 (2010).
  Medline CASGoogle Scholar
• 29  Wina KY, Feng SS. In vitro and in vivo studies on vitamin E TPGS-emulsified poly (D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials27,2285–2291 (2006).• •In vitro drug release study that was carried out following the method of Wina and Feng.
  MedlineGoogle Scholar
• 30  Sarkar S, Das N. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech. Age. Develop.127,391–397 (2006).
  Medline CASGoogle Scholar
• 31  Moragón AC, De Lucas García N, Encarnación López Fernández M, Rodriguez-Manzaneque AS, Jimenez Fraile JA. Antioxidant enzymes, occupational stress and burnout in workers of a prehospitalary emergency service. Eur. J. Emerg. Med.12,111–115 (2005).
  MedlineGoogle Scholar
• 32  Maiti S, Chatterjee AK. Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environ. Tox. Pharm.8,227–235 (2000).
  Medline CASGoogle Scholar
• 33  Mandal AK, Sinha J, Mandal S, Mukhopadhyay S, Das N. Targeting of liposomal flavonoid to liver in combating hepatocellular oxidative damage. Drug Deliv.9,181–185 (2002).
  Medline CASGoogle Scholar
• 34  Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol.186,464–478 (1990).
  Medline CASGoogle Scholar
• 35  Jones BL, Fontanini D, Jarvinen M, Pekkarinen A. Simplified endoproteinase assays using gelatin or azogelatin. Anal. Biochem.263,214–220 (1998).
  Medline CASGoogle Scholar
• 36  Lowry OH, Rosebrough NJ, Farr AL, Randel R. Protein measurement with Folin phenol reagent. J. Biol. Chem.193,265–277 (1951).
  Medline CASGoogle Scholar
• 37  Socha M, Bartecki P, Passirani C et al. Stealth nanoparticles coated with heparin as peptide or protein carriers. J. Drug Target.17,575–585 (2009).
  Medline CASGoogle Scholar
• 38  De Jong WH, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed.3,133–149 (2008).
  Medline CASGoogle Scholar
• 39  Umoh NJ, Lesi OA, Mendy M et al. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver Int.31,215–221 (2011).
  MedlineGoogle Scholar
• 40  Bishayee A, Sarkar A, Chatterjee M. Further evidence for chemopreventive potential of beta-carotene against experimental carcinogenesis: diethylnitrosamine-initiated and Phenobarbital-promoted hepatocarcinogenesis is prevented more effectively by beta-carotene than by retinoic acid. Nutr. Cancer37,89–98 (2000).
  Medline CASGoogle Scholar
• 41  Dasari A, Bartholonew JN, Volonte D, Galbiati F. Oxidative stress induces premature scnescence by stimulating caveolin 1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res.66,10805–10814 (2006).
  Medline CASGoogle Scholar
• 42  Zhi-Ping Y, Li-Juan C, Lin-Yu F et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res.12,3193–3199 (2006).•• ••Illustrates whether vesicular drug suppresses the growth of solid tumors by exploiting the leaky hepatic tumor endothelium and traversing more quickly to malignant cells compared with quercetin.
  MedlineGoogle Scholar
• 43  Shimamoto K, Hayashi H, Taniai E et al. Antioxidant N-acetyl-L-cysteine (NAC) supplementation reduces reactive oxygen species (ROS)-mediated hepatocellular tumor promotion of indole-3-carbinol (13C) in rats. J. Toxicol. Sci.36,775–786 (2011).
  Medline CASGoogle Scholar
• 44  Teufelhofer O, Weiss RM, Parzefall W et al. Promyelocytic HL60 cells express NADPH oxidase and are excellent targets in a rapid spectrophotometric microplate assay for extracellular superoxide. Toxicol. Sci.76,376–383 (2003).
  Medline CASGoogle Scholar
• 45  Savitha S, Tamilselvan J, Anusuyadevi M, Panneerselvam C. Oxidative stress on mitochondrial antioxidant defense system in the aging process: role of DL –alpha-lipoic acid and L-carnitine. Clin. Chem. Acta.355,173–180 (2005).
  Medline CASGoogle Scholar
• 46  Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog.5,14 (2006).
  MedlineGoogle Scholar
• 47  Jayakumar S, Madankumar A, Asokkumar S et al. Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol. Cell Biochem.360,51–60 (2012).
  Medline CASGoogle Scholar
• 48  Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J. Gastroenterol. Hepatol.27,89–93 (2012).
  Medline CASGoogle Scholar
• 49  Liu M, Liu H, Wang X, Chen P, Chen H. IL-6 induction of hepatocyte proliferation through the Tmub1-regulated gene pathway. Int. J. Mol. Med.29,1106–1112 (2012).
  Medline CASGoogle Scholar
• 50  Lee J, Lim KT. Inhibitory effect of phytoglycoprotein (24kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice. J. Pharm. Pharmacol.63,840–848 (2011).
  Medline CASGoogle Scholar
• 51  Sakurai T, Kudo M. Signaling pathways governing tumor angiogenesis. Oncology81,24–29 (2011).•• ••Demonstrates the relevancy of our study as matrix metalloproteinases are currently attracting a large clinical interest as potential drug targets in therapeutic intervention with cancer development.
  Medline CASGoogle Scholar